Company intelligence / Profile preview

ALVA10 Therapeutics

United States

Ownership: Private
Development stage: Other

Overview

Alva10 is a precision medicine diagnostics company focused on bridging the gap between payers, employers, and diagnostic developers. They provide customized diagnostic solutions, particularly utilizing their M.A.T.E. platform, to optimize healthcare spending by ensuring effective use of high-cost therapies across various therapeutic areas.

Therapeutic areas: ImmunologyCardiovascularNeurologyInfectious DiseasesRare DiseasesGastroenterologyOncology
Industry: Molecular Diagnostics

Partnerships

Diaceutics

Beyond the preview

Go deeper on ALVA10 Therapeutics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ALVA10 Therapeutics.

Explore the full profile